Login
$BTCT
$0.74 +$0.01 (1.04%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Current assets
Cash and cash equivalents
Accounts receivable
Prepayments and other current assets
Amounts due from related parties
Digital assets
Total current assets
Non-current assets
Equity method investments
Right-of-use asset
Property and equipment, net
Total non-current assets
Total assets
Current liabilities
Accounts payable
Short term loans
Deferred revenue
Contract liabilities
Current lease liability
Accrued expenses and other payables
Amounts due to related parties
Related Party
Total amounts due to related parties
Total current liabilities
Non-current liability
Lease liability
Total non-current liability
Total liabilities
Shareholders’ equity
Ordinary shares (US$0.06 par value; 200,000,000 shares authorized; 6,434,040 and 9,516,975 shares issued outstanding as of December 31, 2024 and December 31, 2025)
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support